Global Self Monitoring Blood Glucose Market and China Human Vaccine Industry research report are classified and segmented on various aspects to provide possible forecast.
(PRWEB) August 16, 2015
‘The Global Self-Monitoring of Blood Glucose Market to 2025’ is a latest pharma report, covering the pharmaceutical, commercial and strategic developments in the global Self-Monitoring of Blood Glucose (SMBG) market. The report highlights key companies, geographies and products that we believe will deliver strong growth across the next decade. The SMBG market is primarily driven by the growing global diabetic population; a lack of a cure for diabetes; increasing health education among the diabetic population, active reimbursement policies of insurers; the technological advancement aimed at minimal and non-invasive blood glucose testing methods, alongside the availability of blood glucose meters at a nominal cost. ‘The Global Self-Monitoring of Blood Glucose Market to 2025’ report includes over 200 tables, charts and graphs quantifying and forecasting the market in detail. In addition, the report offers 9 profiles of the leading companies in the global SMBG market, alongside 4 expert interviewees offering key insights into the state of the market currently and in the future. Browse more information about this research report at http://www.rnrmarketresearch.com/the-global-self-monitoring-of-blood-glucose-market-to-2025-market-report.html .
Major companies and organizations profiled in ‘Global Self Monitoring Blood Glucose Market’ research report are Abbott Diabetes Care, American Association of Diabetes Educators, American, Bayer Group, Centres for Medicare and Medicaid Services (USA), Carlyle Group, Dipylon Medical AB, Eirus Medical, EyeSense GmbH,GlucoRx, International Diabetes Federation, IHME, JIDP, Johnson & Johnson, Luminous Medical, Merck, National Social Security System (Spain), National Health System (Spain), National Health Services (NHS), National Institute of Health (USA), Nipro Corporation, Prodigy Diabetes Care, Roche Pharmaceuticals, Technomark Life Sciences Corporation, The University of Calgary, Tandem Diabetes Care, Target, Terumo Corporation, Terumo Medical, Ultradian Diagnostics, Veropharm, Wegmans, Walmart, WellPoint, and WHO. Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=263936 .
Topics covered in ‘Global Self Monitoring Blood Glucose Market’ are:
- Executive Summary
- The Global SMBG Market 2015-2025
- The Glucose Test Strips Market 2015-2025
- The Glucose Meters Market, 2015-2025
- The Continuous Glucose Monitoring Market 2015-2025
- Leading Companies in the Global SMBG Market
- SWOT Analysis of the Global SMBG Market 2015-2015
- Expert Opinion
This is a premium research report priced at US$ 2500 for single user PDF license. Inquire for discount on this research report at http://www.rnrmarketresearch.com/contacts/discount?rname=263936 .
‘Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018’, mainly studies the market, competition pattern and segmentations of human vaccine industry in China and analyzes the industry chain, import & export and key enterprises of human vaccine in China. This report analyzes the business performances of 7 key enterprises, including Beijing Tiantan Biological Products Co., Ltd, ChongQing ZhiFei Biological Products Co., Ltd, Walvax Biotechnology Co., Ltd, Liaoning Chengda Co., Ltd (LCD) etc. In 2014-2018, the average growth rate of vaccine in China will maintain at 16%-18%. The main driving factors include implement of the national vaccine immunization plan, increasing receptivity of vaccine by people, the rising trend of initiative vaccination and increase of type, vaccine applications, etc. It can be expected that the market scale of vaccine will hit CNY 40.5 billion in 2018. Browse more information at http://www.rnrmarketresearch.com/research-and-investment-prospect-of-human-vaccine-industry-in-china-2014-2018-market-report.html .
As one of powerful vaccine manufacturing countries in the world, China has 42 vaccine manufacturers with approval license. In 2013, the total of lot release quantity of vaccines was about 755 million doses, increasing by 0.53% over the 751 million doses in 2012. Vaccine manufacturers mainly consist of state-owned enterprises, private enterprises and foreign-funded enterprises in China. Seeing from the lot release quantity of vaccine in 2013, the state-owned enterprises still take the leading position in the vaccine market, with market shares of 62%, followed by private enterprises and foreign-funded enterprises successively, with market shares of 33.77% and 4.23% respectively. Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=271417 .
Topics covered in ‘China Human Vaccine Industry’ are:
- Overview of Human Vaccine Industry
- Development Environment of Human Vaccine in China
- Development of Human Vaccine Industry
- Import and Export of Human Vaccine Industry in China
- Segmented Industries of Human Vaccine
- Key Human Vaccine Enterprises in China
- Investment Analysis on Human Vaccine
This research report available for US$ 2000 for single user PDF license. Inquire for discount on this research report at http://www.rnrmarketresearch.com/contacts/discount?rname=271417 .
Browse more reports on ‘Life Sciences Market’ at http://www.rnrmarketresearch.com/reports/life-sciences .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
1 South Dearborn Street,
21st Floor, Chicago,
Illinois, 60603, USA